Allogeneic hematopoietic stem cell transplant outcome for patients with end stage renal disease on dialysis.
Study #: RT17-01
Study Status: Published
Presentation(s)
2019, ASH (Poster)
2020, TCT Meetings (Poster)
Impact of pretransplantation renal dysfunction on outcomes after allogeneic hematopoietic cell transplantation.
Citation
Farhadfar N, Dias A, Wang T, Fretham C, Chhabra S, Murthy HS, Broglie L, D'Souza A, Gadalla SM, Gale RP, Hashmi S, Al-Homsi AS, Hildebrandt GC, Hematti P, Rizzieri D, Chee L, Lazarus HM, Bredeson C, Jaimes EA, Beitinjaneh A, Bashey A, Prestidge T, Krem MM, Marks DI, Benoit S, Yared JA, Nishihori T, Olsson RF, Freytes CO, Stadtmauer E, Savani BN, Sorror ML, Ganguly S, Wingard JR, Pasquini M.
Transplantation and Cellular Therapy. 2021, May 01: 27(5): 27(5):410-422. doi: 10.1016/j.jtct.2021.02.030. Epub 2021, Feb 26. PMCID:PMC8168834.
PubMed
PMID: 33775617
Abstract